M. Della Giulia

401 total citations
12 papers, 308 citations indexed

About

M. Della Giulia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, M. Della Giulia has authored 12 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 2 papers in Immunology. Recurrent topics in M. Della Giulia's work include Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). M. Della Giulia is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). M. Della Giulia collaborates with scholars based in Italy, Malaysia and United Kingdom. M. Della Giulia's co-authors include B. Jandolo, Francesco Cognetti, Antonio Silvani, Silvia Carpano, Andrea Pace, Edvina Galiè, Antonella Savarese, Loredana Bove, V. Scaioli and A. Pozzi and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Annals of Oncology.

In The Last Decade

M. Della Giulia

12 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Della Giulia Italy 6 193 92 46 44 42 12 308
Sneẑana Šušnjar Serbia 10 144 0.7× 77 0.8× 94 2.0× 12 0.3× 35 0.8× 35 330
Jamie R. Brewer United States 7 206 1.1× 55 0.6× 50 1.1× 57 1.3× 9 0.2× 10 328
Paolo Marolla Italy 10 170 0.9× 24 0.3× 77 1.7× 11 0.3× 44 1.0× 16 322
Lívia Beke Hungary 11 57 0.3× 44 0.5× 105 2.3× 26 0.6× 30 0.7× 33 321
Qiong Zhao China 14 299 1.5× 196 2.1× 145 3.2× 15 0.3× 70 1.7× 28 503
G. Catalano Italy 11 450 2.3× 206 2.2× 181 3.9× 39 0.9× 129 3.1× 34 640
Lara M. Munín Sánchez Spain 10 173 0.9× 37 0.4× 80 1.7× 30 0.7× 75 1.8× 17 302
Sachiko Sugai Japan 6 270 1.4× 65 0.7× 97 2.1× 13 0.3× 55 1.3× 10 438
A. Grothey United States 4 274 1.4× 75 0.8× 38 0.8× 52 1.2× 29 0.7× 8 340
Gillian Moore Ireland 9 130 0.7× 45 0.5× 178 3.9× 5 0.1× 56 1.3× 16 414

Countries citing papers authored by M. Della Giulia

Since Specialization
Citations

This map shows the geographic impact of M. Della Giulia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Della Giulia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Della Giulia more than expected).

Fields of papers citing papers by M. Della Giulia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Della Giulia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Della Giulia. The network helps show where M. Della Giulia may publish in the future.

Co-authorship network of co-authors of M. Della Giulia

This figure shows the co-authorship network connecting the top 25 collaborators of M. Della Giulia. A scholar is included among the top collaborators of M. Della Giulia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Della Giulia. M. Della Giulia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Monica, P. Della, et al.. (2025). Circulating tumor DNA monitoring in advanced mutated melanoma (LIQUID-MEL). PubMed. 8. 100295–100295. 1 indexed citations
2.
Giampieri, Riccardo, Federica Pecci, Alessandro Bittoni, et al.. (2021). P-131 External validation of prognostic ALAN score in patients with inoperable bile duct cancer treated with second-line chemotherapy. Annals of Oncology. 32. S143–S143. 1 indexed citations
3.
Giampieri, Riccardo, Antonio Zizzi, Alessandro Bittoni, et al.. (2020). P-27 Retrospective observational analysis of p53 mutational status as a prognostic factor in TAS-102 treated metastatic colorectal cancer patients. Annals of Oncology. 31. S98–S98. 2 indexed citations
4.
Bittoni, Alessandro, Federica Pecci, M. Della Giulia, et al.. (2020). P-117 Prognostic role of plasmatic exosomal and tissue caveolin-1 in metastatic pancreatic cancer patients. Annals of Oncology. 31. S128–S128. 2 indexed citations
5.
Pace, Andrea, Diana Giannarelli, Edvina Galiè, et al.. (2010). Vitamin E neuroprotection for cisplatin neuropathy. Neurology. 74(9). 762–766. 144 indexed citations
6.
Pace, Andrea, Silvia Carpano, Edvina Galiè, et al.. (2007). Vitamin E in the neuroprotection of cisplatin induced peripheral neurotoxicity and ototoxicity. Journal of Clinical Oncology. 25(18_suppl). 9114–9114. 12 indexed citations
7.
Crucitti, Giuliana Cuzzucoli, et al.. (2001). [Treatment of malignant pleural effusion by pleurodesis with talc].. PubMed. 52(5). 541–7. 1 indexed citations
8.
Rinaldi, Monica, Lucio Crinò, Giorgio V. Scagliotti, et al.. (2000). A three-week schedule of gemcitabine–cisplatin in advanced non-small-cell lung cancer with two different cisplatin dose levels: A phase II randomized trial. Annals of Oncology. 11(10). 1295–1300. 46 indexed citations
9.
Vici, Patrizia, et al.. (1999). [Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer].. PubMed. 149(4). 255–9. 1 indexed citations
10.
Mosconi, Anna Maria, Giorgio V. Scagliotti, Giovanni Selvaggi, et al.. (1998). Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.. PubMed. 25(4 Suppl 9). 23–6. 17 indexed citations
11.
Garaci, Enrico, M López, G Bonsignore, et al.. (1995). Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-αl and interferon-α2a. European Journal of Cancer. 31(13-14). 2403–2405. 36 indexed citations
12.
Nardi, Marco, F. Cognetti, C. F. Pollera, et al.. (1990). Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.. Journal of Clinical Oncology. 8(6). 1036–1041. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sneẑana Šušnjar Breakdown of academic impact, for papers by Jamie R. Brewer Breakdown of academic impact, for papers by Paolo Marolla Breakdown of academic impact, for papers by Lívia Beke Breakdown of academic impact, for papers by Qiong Zhao Breakdown of academic impact, for papers by G. Catalano Breakdown of academic impact, for papers by Lara M. Munín Sánchez Breakdown of academic impact, for papers by Sachiko Sugai Breakdown of academic impact, for papers by A. Grothey Breakdown of academic impact, for papers by Gillian Moore
Rankless by CCL
2026